The Fedtrade® podcast recently interviewed Daniel Clark, Vice President and Director of Business Development at the New York City Economic Development Corporation (NYCEDC), as part of our SelectUSA Investment Summit Spotlight series. NYCEDC is a mission-driven, nonprofit organization that works for a vibrant, inclusive, and globally competitive economy for all New Yorkers. They take a
The Fedtrade® podcast recently interviewed Bill Noonan, Chief Business Development Officer of Choose New Jersey, as part of our SelectUSA Investment Summit Spotlight series. Choose New Jersey is the state’s leading non-profit business attraction organization, inspiring businesses, entrepreneurs, and innovators to make New Jersey their home. They provide a range of free, confidential resources and
The Fedtrade® podcast recently interviewed Tony Davis, Head of North and Latin America at the Australian Trade and Investment Commission (Austrade). Austrade helps grow Australia’s prosperity by delivering quality trade and investment services to businesses, accelerates growth in Australia’s tourism sector. and promotes Australia’s education to the world.
Learn more about Austrade on their website or
Introduction
On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for drugs and biological products. The draft guidance – the first of its kind from the agency – aims to enhance the efficacy and accuracy of the drug approval process, ensuring that applications incorporating AI meet rigorous
On December 3, 2024, Bristol Myers Squibb announced a collaboration agreement with three-year-old startup AI Proteins.[1] According to its founder, Chris Bahl, PhD, AI Proteins uses “AI, synthetic biology, and laboratory automation to rapidly design and optimize novel miniproteins with ideal drug-like properties.”[2] The end goal of this collaboration is likely biologic products
The utilization of artificial intelligence (“AI”) is becoming ubiquitous across a wide range of industry sectors. The biotech industry is no exception.
AI-driven platforms have become increasingly useful to biotech innovators in many areas including in discovering and developing drugs. For example, a 2022 article by McKinsey & Company estimated that nearly 270 companies have
Critical and Emerging Technologies (CET) are of vital importance to the U.S. government. Therefore, it has made CET funding and support a top priority.
The U.S. National Security Strategy identifies expanding economic prosperity and opportunity as one of three primary goals.
The following critical and emerging technology areas are deemed of critical importance to U.S.
We recently spoke with Satish Grampurohit, Co-founder and CEO, Cogniquest Technologies, Bengaluru, India. Cogniquest is a provider of an AI-enabled platform that powers Intelligent Document Processing (IDP). The Cogniquest AI Platform helps businesses reduce the time employees spend on manual data collection and empowers them to focus on more critical tasks. To learn more about
The Unted States Patent and Trademark Office (USPTO) recently published new guidance on subject-matter eligibility as related to Artificial Intelligence (AI), opening a written comment window to respond with a deadline of September 16, 2024. The guidance was brought about by an October 2023 Executive Order on the “Safe, Secure, and Trustworthy Development and
America’s Seed Fund provides innovation funding for startups and small businesses across technology areas and markets. To discuss U.S. federal funding opportunities and eligibility, contact us at fedtrade@rothwellfigg.com
America’s Seed Fund is a startup innovation funding program of the U.S. National Science Foundation. Its purpose is to provide financial support to technology startups during the